## Note
nid: 1485219985329
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#B&B::17_Psych::04_Pharm::03_Antipsychotics, #AK_Step1_v11::#FirstAid::13_Psychiatry::03_Pharm::05_Atypical_Antipsychotics, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#OME_banner::Clinical::12_Psychiatry, #AK_Step1_v11::#Physeo::09_Pharm::13_Psychiatric::15_Typical_Antipsychotics, #AK_Step1_v11::#Physeo::09_Pharm::13_Psychiatric::16_Atypical_Antipsychotics, #AK_Step1_v11::#Pixorize::03_Pharm::01_General::D2_(Dopamine)_Receptors, #AK_Step1_v11::#Pixorize::03_Pharm::16_Psych::Atypical_Antipsychotics, #AK_Step1_v11::#SketchyPharm::06_Neuro/Psych::05_Antipsychotics_&_Parkinsons::02_Second_generation_antipsychotics, #AK_Step1_v11::#UWorld::10000-99999::15000-15999::15397, #AK_Step1_v11::^Other::^HighYield::1-HighYield, #AK_Step1_v11::^Systems::Neuro::Pharmacology, #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::4fm, #AK_Step2_v11::!Shelf::FM, #AK_Step2_v11::!Shelf::FM::no_dupes, #AK_Step2_v11::!Shelf::Psych, #AK_Step2_v11::!Shelf::Psych::no_dupes, #AK_Step2_v11::#AMBOSS, #AK_Step2_v11::#AMBOSS::PSYCH, #AK_Step2_v11::#B&B::03_Psych::04_Psychopharmacology::02_Antipsychotics::03_Atypical_antipsychotics, #AK_Step2_v11::#OME::12_Psychiatry::15_Pharm_2, #AK_Step2_v11::#OME_banner, #AK_Step2_v11::#Resources_by_rotation::FM::ome::psych::pharm, #AK_Step2_v11::#Resources_by_rotation::Psych::fapsych::pharm, #AK_Step2_v11::#Resources_by_rotation::Psych::uworld::dorian, #AK_Step2_v11::#Resources_by_rotation::Psych::uworld::zanki, #AK_Step2_v11::#Subjects::Psychiatry::07_Psychotic_Disorders::*Antipsychotics::*Basics, #AK_Step2_v11::#Subjects::Psychiatry::07_Psychotic_Disorders::*Antipsychotics::Atypical_Antipsychotics::*Basics, #AK_Step2_v11::#UWorld::1000-9999::2000-2999::2499, #AK_Step2_v11::Original_decks::Dorian::fam::ome::psych::pharm, #AK_Step2_v11::Original_decks::Dorian::psych::fapsych::pharm, #AK_Step2_v11::Original_decks::Dorian::psych::uw, #AK_Step2_v11::Original_decks::Zanki_Step_2::Psych::UW_Psych
markdown: false

### Text
<div>
  Which <u>serotonin receptor</u> is <i>antagonized</i> by many
  <b>atypical antipsychotics</b>?
</div>
<div>
  {{c1::5-HT<sub>2A</sub>}}
</div>

### Extra
<img src="paste-3899830305232.jpg">

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-166460047491075.jpg"><img src=
"paste-30588757082115%20(1).jpg">

### Sketchy
<div>
  <i>Sketchy Pharmacology: Neuro/Psych</i>
</div><img src=
"paste-ddcca34952999c38cdafbd6ff78c4f97231dcd37.png"><img src=
"paste-bb51141a5de06f300139d6e7bb15e995d0b8e3bf.png"> <a href=
"https://dashboard.sketchy.com/study/medical/courses/medical-pharmacology/units/medical-pharmacology-neuro-psych/videos/medical-pharmacology-neuropsych-antipsychotics-and-parkinsons-second-generation-antipsychotics?utm_source=anki&utm_medium=partnership&utm_campaign=february_update&utm_content=medical">
Watch Second generation antipsychotics</a>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/psychiatry?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_4.png"></a>
</div>

### Additional Resources
<i>the added serotonin receptor binding of SGAs (in addition to
D<sub>2</sub> antagonism) <u>reduces</u> the likelihood of
extrapyramidal side effects</i>

### One by one

